US EditionWegovy Expands $499-Per-Month Offering to Additional Cash-Paying Patients
Summary by westorlandonews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
All
Left
Center
Right
Novo Nordisk Acquires Lexicon’s LX9851 for $1B to Expand Weight Loss Drug Portfolio
Lexicon Pharmaceuticals (Lexicon), a U.S. biopharmaceutical company, announced recently in The Woodlands, Texas, that it has entered into an exclusive licensing agreement with Danish pharmaceutical … Novo Nordisk Acquires Lexicon’s LX9851 for $1B to Expand Weight Loss Drug Portfolio Read More » The post Novo Nordisk Acquires Lexicon’s LX9851 for $1B to Expand Weight Loss Drug Portfolio first appeared on GeneOnline News. The post Novo Nordisk Acq…
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
